Dissertation > Excellent graduate degree dissertation topics show
Research on CP2/P30 Bivalent DNA Vaccine and Subunit Vaccine Against Cryptosporidium
Author: LiChunYu
Tutor: ZhangXiChen
School: Jilin University
Course: Preventive Veterinary Medicine
Keywords: Cryptosporidium parvum DNA vaccine Subunit vaccine
CLC: R392
Type: Master's thesis
Year: 2010
Downloads: 60
Quote: 6
Read: Download Dissertation
Abstract
|
Cryptosporidium (Cryptosporidium) is a zoonotic parasitic protozoa, is not only one of the important pathogens of humans and animals diarrhea, with the occurrence of AIDS epidemic. Mainly parasitic in the epithelial cells of the gastrointestinal tract, poultry respiratory mucosa of humans and other mammals, which caused the disease called cryptosporidiosis. Cryptosporidiosis are widely distributed human and animal infection rate, and serious harm, clinically severe watery diarrhea as the main feature. Currently no effective drug for the treatment and prevention of cryptosporidiosis. Therefore, this disease is important parasitic disease of the future medical and veterinary academia prevention. Many scholars believe that the vaccine is the potential of the precautionary approach. Cryptosporidium parvum explore CP2/P30 gene immune protective effect of CP2, P30 gene primers were designed using recombinant DNA technology CP2, P30 gene and two genes gene eukaryotic expression vector pVAX-1 is connected in series construct recombinant eukaryotic expression vector, the two genes alone and tandem cloned into the prokaryotic expression vector the PET28-a in the Construction of prokaryotic expression vector. Recombinant eukaryotic expression plasmid transfected Hela cells, and its expression in eukaryotic cells by indirect immunofluorescence method validation; to express recombinant CP2, P30, and CP2/P30 protein prokaryotic expression vector transformed into E. coli. Nucleic acid vaccines and subunit vaccines goats were immunized mice and during pregnancy detection its immune protection force. The results show that, amplification the CP2, P30 open reading frame, show homology Blast than 99.41% and 99.91%, respectively, after restriction enzyme digestion showed that the vector was successfully constructed. Hela cells after recombinant plasmid in the the Hela fine after transfection by indirect immunofluorescence method detected a specific protein. SDS-PAGE protein bands were detected, consistent with the size of the target protein, total protein was extracted and confirmed by Western blot test resulting protein has reactogenicity; nucleic acid vaccine Protection Results showed that the experimental group compared with the control group, the specific antibody titers degrees, CD4 and CD8 T lymphocyte count differences were highly significant (p lt; 0.01), CD4 / CD8 T-lymphocyte count value of the difference was not statistically significant (p gt; 0.05). Experimental group of mice after the attack insect discharge oocysts time decreased by two days, the worm reduction rate and the control group was significantly different, with the empty vector control group were not statistically significant (p gt; 0.05), reduced oocyst maximum of 63.5% . The pregnant goat birth Lamb worm reduction rate of 47.3%. Recombinant CP2, P30 protein and two gene tandem subunit vaccine protection results show that, with the immune increase in the number of antibody titers gradually increased, the test group compared with the control group, a significant difference (p lt; 0.01). CD4 and CD8 T lymphocyte count with the control group compared to the significant difference (p lt; 0.01), CD4 / CD8 T-lymphocyte count value of the difference was not statistically significant (p gt; 0.05). The test mice worm reduction rate significantly, worm reduction rates of up to 61.5%. The pregnant goat birth Lamb worm reduction rate of 42.1%.
|
Related Dissertations
- DNA Prime/Protein Boost of Japanse Edcephalitis Virus NS1 Protein to Improve Immune Response in Mice,R392
- The Preliminary Study of the pcDNA3.1(+)-SjP14 Nanometer Microballoon-DNA Vaccines,R392.1
- Study on Pharmacokinetics and Spatial and Temporal Expression in Mice of DNA Vaccine against Schistosoma Japonicum,S855.91
- Construction of Coexpression Vector Containing Capripoxvirus P32 Gene and Goat CD58 Gene and Immune Activity Analysis of the Expression Production,S858.26
- Research of Cryptosporidium Species and Genotypes in Pre-weaned Calves in Henan Province,S858.23
- Preparation of Replicative Alphavirus Particle Vaccine and Dc-targeting Preliminary Research on Alphavirus Particle Vaccine Vector System,R392
- Development and Application of Bivalent Nucleic Acid Vaccine for Cryptosporidium Parvum CP405/CP585 in Animals,S852.52
- Construction of Nucleic Acid Vaccine Containing GAM56 Gene from Eimeria Maxima and Its Immune Efficacy,S858.31
- Isolation and Identification of Local Strains of Enterovirus 71, Construction of Eukaryotic Expression Vector Carring VP1 and Study of Its Immunological,R373
- The Immunology of Two Herpes Simplex Virus Type Ⅰ Glycoprotein B DNA Vaccines,R392
- Expression of IBDV Structural Protein VP2 Gene in Bombyx Mori and Its Immune Effect As Subunit Vaccine,S855.3
- Development of Subunit Vaccine of Streptococcus Suis Type 2 and Actinobacillus Pleuropneumoniae,S858.28
- Essential Sequences of Influenza A and B Virus Hemagglutinin DNA to Provide Protection Against Lethal Viral Infection,R373
- Biosafety Evaluation and Field Trial of Rabies Virus Glycoprotein and Nucleoprotein "Bivalent" DNA Vaccine in Dogs,S852.52
- The use of attenuated Salmonella typhimurium developed gastric cancer MG7-Ag mimotope oral DNA vaccine,R735.2
- Screening and Localization of Adherence-related Protein of Cryptosporidium Parvum Sporozoites,R382
- Construction and Immunogenicity of rDNA Against Multi-subtype Influenza a Virus,R392
- Development and Application of Bivalent Nucleic Acid Vaccine for Cryptosporidium Parvum CP12/CP21 in Animals,S852.5
- Prokaryotic Expression of SjFABP and SjGST of Schistosoma Japonicum and Study of Multivalent DNA Vaccine,Q789
- Experimental Study on Genetic Engineering Subunit Vaccine Against Bordetella Pertussis,R392
CLC: > Medicine, health > Basic Medical > Medical Immunology
© 2012 www.DissertationTopic.Net Mobile
|